The European Commission has approved a €665 million Austrian scheme to support non-profit organisations (NPOs) and their related entities in the context of the coronavirus outbreak. The scheme was approved under the State aid Temporary Framework.
Executive Vice-President Margrethe Vestager, in charge of competition policy, said: “In Austria there is a longstanding tradition and a wide variety of non-profit organisations ranging from small voluntary fire brigades to large alpine associations, from music orchestras to the Austrian Red Cross with over 1 million members. Altogether almost half of the Austrian population is a member of at least one of these organisations. This scheme will support the non-profit sector, which is critical to the Austrian community and culture.”
Austria notified the Commission under the Temporary Framework a scheme with an overall budget of €665 million to support NPOs active in Austria.
Public events are an important source of funding for NPOs in Austria. The necessary emergency measures put in place to limit the spread of the coronavirus, including the prohibition of public events, have affected the NPOs’ access to funding and endangered their operations. Under the scheme, aid will take the form of direct grants to non-profit organisations and their related entities, with the aim of providing the liquidity support necessary to preserve their activities, which have been severely damaged by the coronavirus outbreak.
The Commission found that the Austrian scheme is in line with the conditions set out in the Temporary Framework. In particular, (i) the aid will be limited to €100,000 per company active in the primary production of agricultural products, €120,000 per company active in the fishery and aquaculture sector and €800 000 per company active in other sectors and (ii) aid will be granted on 31 December 2020 at the latest.
Full Content: Europa
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Pfizer Settles Remaining Effexor XR Antitrust Claims for $25.5 Million
Apr 29, 2024 by
CPI
South Korean Regulator Approves LG Uplus and Kakao Mobility EV Charging Venture
Apr 29, 2024 by
CPI
Federal Judge Dismisses Doctors’ Antitrust Suit Against Ohio Health System
Apr 29, 2024 by
CPI
Paramount CEO Bob Bakish Steps Down as Merger Inches Closer
Apr 29, 2024 by
CPI
EU Brands Apple’s iPadOS as Gatekeeper in Tech Crackdown
Apr 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI